Navigation Links
OncoGenex in Medical News
BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company
...in net proceeds from the sale of common stock to a subsidiary of Cadila Pharmaceuticals as part of a new strategic alliance. On July 20, 2009, oncogenex Pharmaceuticals, Inc. raised approximately $9 million in net proceeds from a direct common stock offering to certain institutional investors. O...Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
...-427 are antisense drugs co-discovered by Isis and oncogenex (Nasdaq: OGXI ) and Isis licensed its rights to OGX-011 to oncogenex Pharmaceuticals, Inc. In addition, new results f...s with cancer were also presented. Both Lilly and oncogenex are also developing additional anti-cancer drugs i...Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
...hat showed iCo-007 appears to be well tolerated and demonstrates promising signs of activity in patients with diffuse diabetic macular edema. oncogenex reached an agreement with the FDA on the design of a second Phase 3 registration trial of OGX-011 that features durable pain palliation as the primary...Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
...the annual ASCO meeting in Chicago. Both Lilly and oncogenex are developing additional anticancer drugs discove... antisense drugs being developed by Isis' partners oncogenex and Lilly continue to demonstrate the potential of antisense technology to treat multiple cancers. oncogenex presented Phase 2 data on OGX-011 demonstrating be...Isis Reports Financial Results and Highlights for First Quarter of 2008
... -- Isis received a $2 million milestone payment with the selection of an antisense drug candidate to advance into development. o oncogenex reported encouraging Phase 2 data of OGX-011, an antisense drug in clinical studies in patients with advanced prostate or lung cancers. ...Isis Reports Financial Results and Highlights for Fiscal year 2007
...rugs discovered by Isis to treat cancer. * oncogenex reported encouraging Phase 2 data for OGX-011, an ...y agents alone, based on historical controls. * oncogenex initiated Phase 1 clinical studies of OGX-427, an ...ntial of antisense drugs. Already this year, oncogenex reported Phase 2 results for OGX-011 in prostate ...OncoGenex in Medical Technology
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...ned $1.4 million of revenue when Isis sold drug to oncogenex Pharmaceuticals, Inc. Isis' re...cal Oncology (ASCO) annual meeting. oncogenex reported results of a randomized Phase 2 trial of ...for patients treated with docetaxel alone. oncogenex reported that OGX-427 was well tolerated as a mono......icals, Inc. (Nasdaq: ISIS ) announced today that oncogenex Pharmaceuticals, Inc. provided positive survival r...he latest results from OGX-011 and look forward to oncogenex announcing the full results of the study next year...llow-up of approximately 30 months for both arms. oncogenex indicates that additional survival updates will be...
... VANCOUVER, April 17, 2007 /PRNewswire/ - oncogenex Technologies Inc. announced today data from a Phas...ing chemotherapy, and facilitate tumor cell death. oncogenex is developing OGX-011 in collaboration with Isis P...rt provided by OncoGenex Technologies Inc. About oncogenex ...
OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO
...ARLSBAD, CA, May 31, 2007 /PRNewswire-FirstCall/ - oncogenex Technologies Inc. and Isis Pharmaceuticals, Inc. t...ing chemotherapy, and facilitate tumor cell death. oncogenex and Isis are collaborating on development of OGX-011. About oncogenex ...OncoGenex in Biological Technology
FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals' Lead Product Candidate OGX-011
BOTHELL, WA and VANCOUVER, Aug. 22 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: OGXI ) announced today that OGX-011, also known as custirsen sodium, received Fast Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive meta...Satisfies initial listing requirements with NASDAQ; Stock Symbol 'OGXI' Implements immediate restructuring program, which extends cash runway while focusing on clinical pipeline programs BOTHELL, WA, Aug. 21 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (formerly Sonus Pharmaceut...
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
- Combined Company Will Have Three Oncology Products in Clinic - - Lead Candidate Targets Hormone Refractory Prostate and Non-Small Cell Lung Cancers - - Conference Call to be Held Wednesday, May 28th, at 11:00 a.m. Pacific Time...OncoGenex Reports Second Quarter 2009 Financial Results
...WA, and VANCOUVER, Aug. 6 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company...ing consolidated results reflect the operations of oncogenex Technologies Inc. ("OncoGenex Technologies") prior...s, Inc. ("Sonus"), and the consolidated results of oncogenex thereafter. The loss attributable to common shar...OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
... WA and VANCOUVER, Aug. 3 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals (NASDAQ: OGXI ) announced today ...ter financial results on Thursday, August 6, 2009. oncogenex will host a conference call and live webcast at 4:... be accessed on the Investor Relations page of the oncogenex Web site at www.oncogenex.com . Alternatively, yo...OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
...WA and VANCOUVER, July 24 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced ... purposes. The shares of common stock offered by oncogenex in this transaction were offered and sold pursuant...ission's web site at http://www.sec.gov , or from oncogenex Pharmaceuticals, Inc., 1522 217th Pl. SE, Suite 10...OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
...WA and VANCOUVER, July 20 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced ...ected to provide gross proceeds of $9.5 million to oncogenex before deducting costs associated with the offerin... 24, 2009. The shares of common stock offered by oncogenex in this transaction will be issued pursuant to the...New Report Just Published: World Prostate Cancer Therapeutics Market Report
...g Receives FDA Approval for Degarelix in Prostate Cancer II-53 Isis and oncogenex Reveals Positive results of OGX-011 Molecule in HRPC II-53 Antisoma... BioWa Obtains License for Anti-FGF8 Antibody from Kyowa Hakko II-87 oncogenex and Isis Pharmaceuticals Expand Partnership II-87 Caprion and AstraZene...OncoGenex Pharmaceuticals Added to Russell Indexes
...A, and VANCOUVER, June 30 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals, Inc. (NASDAQ: OGXI ), a biophar...l.com/Indexes/performance/default.asp . About oncogenex oncogenex is a biopharmaceutical company committed to the de...OncoGenex Pharmaceuticals Files Shelf Registration Statement
...WA and VANCOUVER, June 26 /PRNewswire-FirstCall/ - oncogenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced ...o fund our Phase 3 clinical trials for OGX-011." oncogenex elected to terminate its previous shelf registrati...ent and MJDS prospectus, respectively, will permit oncogenex Pharmaceuticals to sell, from time to time over a ...Other TagsOther Contents
ROSALKISZASZNACCHODAminotransferaseASPECartonsMicroWriteMicroslideDrawerSortersEnvelopesMailersWooden
(Date:6/17/2013)... The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer’s dementia, ... journal Radiology. , “Findings of MTBI bear a ... said the study’s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. “Additional research ...
(Date:6/17/2013)... 18, 2013 Essential tremor (ET) is ... estimated 10 million people in the United States, and ... clear understanding what causes ET, there are no medications ... cure. Tulips for Tremor© is the International Essential Tremor ... of and a cure for this life-altering neurological condition. ...
(Date:6/17/2013)... BROOK, Ill. The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer,s dementia, ... journal Radiology . , "Findings of MTBI ... Alzheimer,s dementia," said the study,s lead author, Saeed Fakhran, ... Neuroradiology at the University of Pittsburgh School of Medicine. ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based ... as expertly designed carpet steam cleaner and vapor steam ... for apartment dwellers and homeowners. The commercial steam cleaner ... and pressure levels up to 75 psi to clean ... to clean carpet spots and areas in homes, but ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Nearly 26 ... as many as 79 million adults are estimated to ... to prevent type 2 diabetes through weight loss and ... can help bring your blood sugar level back within ... and factors, 101 Medical Weight Loss physicians can help ...
Breaking Medicine News(10 mins):Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4[0] RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities[0] International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor[0] Concussion patients show Alzheimer's-like brain abnormalities[0] Daimer Ships Vapor Steam Cleaner For Homeowners[0] Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss
(Date:6/17/2013)... by fungi, bacteria, and algae, is a common component ... used in the medical field it,s approved by ... fluids and used during surgery as a substance that ... other drugs. , Now Profs. Ehud Gazit and Daniel ... and Biotechnology and the Sagol School of Neuroscience, along ...
(Date:6/17/2013)... will be the topics under discussion during the ... the third consecutive year, this will be a ... experiences among members of Academy, Business, Educators, Entrepreneurs, ... speakers: Elisa Martn Garijo (IBM South Europe), Chris ... Mary O,Donovan (Hovione), among others. E3 Forum - ...
(Date:6/17/2013)... available in French . ... older mice with Alzheimer,s disease can be reversed with treatment. ... Hospital - The Neuro, at McGill University and at Universit ... receptor in the brain of mice with advanced Alzheimer,s disease ... the Journal of Neuroinflammation in May, also suggest ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |